Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-1764-2026

Burlington Medical, LLC recalls Burlington Medical

Burlington Medical, LLCNewport News, VA, United StatesReported Apr 8, 2026 · 3 months ago
Legal News Analyst ·

Reason for recall

Potential for attenuation degradation over time, decreasing the lifespan.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Burlington Medical, Blockers.

Lot / code information

Serial #
are affected that were manufactured with Xenolite 800 attenuation material from 01/16/2025 to 01/21/2026. 1
Model
R8BLOCKER1
UDI
(Product Code): 00840331272895 (BLOCKER8-R8BLOCKER1). 2
Model
R8BLOCKER2
UDI
(Product Code): 00840331272901 (BLOCKER8-R8BLOCKER2). 3
Model
R8BLOCKER3
UDI
(Product Code): 00840331272918 (BLOCKER8-R8BLOCKER3). 4
Model
R8BLOCKER4
UDI
(Product Code): 00840331272932 (BLOCKER8-R8BLOCKER4). 5
Model
R8BLOCKER5
Show 11 more code fields
UDI
(Product Code): 00840331272949 (BLOCKER8-R8BLOCKER5). 6
Model
R8BLOCKER6
UDI
(Product Code): 00840331272956 (BLOCKER8-R8BLOCKER6). 7
Model
S8BLOCKER1
UDI
(Product Code): 00840331272963 (BLOCKER8-S8BLOCKER1). 8
Model
S8BLOCKER2
UDI
(Product Code): 00840331272970 (BLOCKER8-S8BLOCKER2). 9
Model
S8BLOCKER3
UDI
(Product Code): 00840331272987 (BLOCKER8-S8BLOCKER3). 10
Model
U8BLOCKER1
UDI
(Product Code): 00840331273038 (BLOCKER8-U8BLOCKER1)

What the firm is doing

Burlington Medical notified consignees on about 02/11/2026 via "URGENT - FIELD SAFETY NOTICE (FSN)" letter. Consignees were instructed to ensure all users of the specific Burlington Medical radiation protection garments made aware of this Recall Notice, review inventory for affected units, arrange for the return of those affected units for proper disposal, and complete and return the Recall Response Form. Consignees were also instructed to notify appropriate individuals within your organization and to any organization where the potentially affected devices were transferred or sold.

DistributionShow details

Worldwide distribution. Nationwide distribution in the US and international distribution to Canada, Australia, Bangladesh, Chile, Hong Kong, India, Mexico, Malaysia, Panama, Singapore, Thailand, Taiwan, Uruguay, and Vietnam.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Source: U.S. FDA openFDA device enforcement reports. This summary is informational and may lag or differ from the official record. Always verify against the FDA before acting.

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls